MediWound Ltd. (MDWD) vs Veraxa Biotech AG (VRXA)

MediWound Ltd. MDWD 11.85 −2.95%
Veraxa Biotech AG VRXA 1.11 +0.91%

MediWound Ltd. and Veraxa Biotech AG are both Biotechnology companies. MediWound Ltd. and Veraxa Biotech AG are of similar size ($162.5M and $157.6M).

Metric	MDWD	VRXA	Biotechnology median
P/E	n/m	—	8.50
P/S	12.87	—	9.71
P/B	4.28	—	2.13
Price to free cash flow	n/m	—	20.82
EV/EBITDA	n/m	—	0.64
EV/Sales	9.97	—	9.21
Earnings yield	(13.50%)	—	(33.15%)
Free cash flow yield	(18.71%)	—	(25.50%)

Metric	MDWD	VRXA	Biotechnology median
Gross margin	15.46%	—	65.16%
Operating margin	(267.75%)	—	0.00%
Net margin	(170.10%)	—	0.00%
Free cash flow margin	(240.47%)	—	0.00%
Return on equity	(75.42%)	—	(56.36%)
Return on assets	(29.06%)	—	(48.04%)
Return on invested capital	(6,551.77%)	—	0.00%

Metric	MDWD	VRXA	Biotechnology median
Revenue growth (TTM)	(40.26%)	—	6.02%
EPS growth (last fiscal year)	30.69%	—	30.26%
Revenue growth, 5-year CAGR	(4.87%)	—	9.41%
Net income growth, 5-year CAGR	0.00%	—	0.00%

Metric	MDWD	VRXA	Biotechnology median
Debt to equity	0.00	—	0.00
Current ratio	2.32	—	4.72
Net debt to EBITDA	2.27	—	0.96

Metric	MDWD	VRXA	Biotechnology median
Dividend yield	—	—	0.09%
Payout ratio	—	—	—

Metric	MDWD	VRXA	Biotechnology median
Market cap	157.63m	162.50m	135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack